Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,120.50
-80.50 (-1.55%)
Oct 15, 2026, 3:28 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 612.23 billion as of October 15, 2026. It is the 2,942nd most valuable company in the world and the 171st biggest in India. Its market cap has decreased by 6.78% in one year.
Market Cap
612.23B
Enterprise Value
597.38B
Revenue
150.81B
Global Rank
Country Rank
#171 India
PE Ratio
28.38
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 612.23B, an increase of 270.59%. That is a compound annual growth rate of 12.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 612.23B | -7.01% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.12T |
| Laurus Labs | 1.10T |
| Cipla | 1.06T |
| Mankind Pharma | 964.35B |
| Aurobindo Pharma | 956.80B |
| Glenmark Pharmaceuticals | 633.82B |
| Gland Pharma | 502.90B |
| Ipca Laboratories | 484.85B |